Olysio and Sovaldi: Two new drugs for Hepatitis C
Hepatitis C is a major public health problem, especially in Southeast Asia. Interferon and ribavirin have been the standard of care in various combinations. The literature supports intereferon with the two recently FDA approved oral medications that can be used in combination with the current antiviral regimen or to replace the injectable component of the regimen, peginterferon alfa. The two new drugs are Olysio (simeprevir) capsules and Sovaldi
Read more